These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 6998048

  • 1. A screening test for renovascular hypertension by means of orally active angiotensin I converting enzyme inhibitor, captopril (SQ 14225).
    Imai Y, Abe K, Otsuka Y, Sakurai Y, Yoshinaga K.
    Tohoku J Exp Med; 1980 Jul; 131(3):311-2. PubMed ID: 6998048
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Reactive hyper-reninaemia to angiotensin blockade identifies renovascular hypertension.
    Case DB, Atlas SA, Laragh JH.
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():313s-316s. PubMed ID: 232024
    [Abstract] [Full Text] [Related]

  • 4. [The captopril test in nonselected hypertensive patients: absence of value for screening of renovascular patients and for unilateral small kidneys].
    Idrissi A, Boudailliez B, Renaud H, Makdassi R, Westeel PF, el Esper N, Fievet P, Remond A.
    Nephrologie; 1988 Dec; 9(2):77-81. PubMed ID: 3050580
    [Abstract] [Full Text] [Related]

  • 5. Discrimination of renovascular from essential hypertension by converting enzyme inhibition with an orally active compound.
    Fagard R, Amery A, Lijnen P, Roussel-Deruyck R.
    Acta Clin Belg; 1982 Dec; 37(1):13-22. PubMed ID: 7046321
    [No Abstract] [Full Text] [Related]

  • 6. Effects of angiotensin I converting enzyme inhibitor (SQ 14,225) on the responses of blood pressure and steroid hormone to angiotensin II and ACTH infusion in hypertensive subjects.
    Ueda Y, Honda M, Hatano M.
    Jpn Circ J; 1982 Mar; 46(3):267-73. PubMed ID: 6278173
    [Abstract] [Full Text] [Related]

  • 7. Captopril stimulation of differential renins in renovascular hypertension.
    Lyons DF, Streck WF, Kem DC, Brown RD, Galloway DC, Williams GR, Chrysant SG, Danisa K, Carollo M.
    Hypertension; 1983 Mar; 5(4):615-22. PubMed ID: 6345367
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs.
    Vollmer RR, Boccagno JA, Steinbacher TE, Horovitz ZP, Murthy VS.
    J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
    Lechi A, Covi G, Capuzzo MG, Lechi C, Minuz P, Delva P, Scuro LA.
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
    [Abstract] [Full Text] [Related]

  • 12. Effect of the converting-enzyme inhibitor SQ 14 225 (captopril) in early one-kidney, one-clip hypertension in the rat.
    Vandongen R, Tunney A, Martinez P.
    Clin Sci (Lond); 1981 Apr; 60(4):387-92. PubMed ID: 7018794
    [Abstract] [Full Text] [Related]

  • 13. Use of captopril in the diagnosis of renal hypertension.
    McGrath BP, Matthews PG, Johnston CI.
    Aust N Z J Med; 1981 Aug; 11(4):359-63. PubMed ID: 7030291
    [Abstract] [Full Text] [Related]

  • 14. Active and inactive renin after captopril (SQ 14225) administration in hypertensive patients.
    Goto T, Abe K, Otsuka Y, Seino M, Ito T, Imai Y, Haruyama T, Sato M, Hiwatari M, Sato K, Omata K, Kasai Y, Tajima J, Yoshinaga K.
    Tohoku J Exp Med; 1983 Jan; 139(1):103-11. PubMed ID: 6340244
    [Abstract] [Full Text] [Related]

  • 15. Captopril-stimulated renal vein renin in hypertensive patients with or without renal artery stenosis.
    Tomoda F, Takata M, Ohashi S, Ueno H, Ikeda K, Yasumoto K, Iida H, Sasayama S.
    Am J Hypertens; 1990 Dec; 3(12 Pt 1):918-26. PubMed ID: 2081013
    [Abstract] [Full Text] [Related]

  • 16. Humoral effects of the oral converting-enzyme inhibitor SQ 14,225 in hypertensive patients in supine and tilted position.
    Morganti A, Pickering TG, Lopez-Ovejero J, Laragh JH.
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():149s-152s. PubMed ID: 232018
    [No Abstract] [Full Text] [Related]

  • 17. Improved diagnosis of unilateral renal artery lesions after captopril administration.
    Thibonnier M, Joseph A, Sassano P, Guyenne TT, Corvol P, Raynaud A, Seurot M, Gaux JC.
    JAMA; 1984 Jan 06; 251(1):56-60. PubMed ID: 6361288
    [Abstract] [Full Text] [Related]

  • 18. Renal artery stenosis with normal angiotensin II values. Relationship between angiotensin II and body sodium and potassium on correction of hypertension by captopril and subsequent surgery.
    Atkinson AB, Brown JJ, Davies DL, Leckie B, Lever AF, Morton JJ, Robertson JI.
    Hypertension; 1981 Jan 06; 3(1):53-8. PubMed ID: 7009427
    [Abstract] [Full Text] [Related]

  • 19. [The captopril test--an aid in the detection of scarring nephropathy as a cause of arterial hypertension in children].
    Peco-Antić A, Nastić-Mirić D, Babić D, Kostić M.
    Srp Arh Celok Lek; 1999 Jan 06; 127(9-10):305-11. PubMed ID: 10649899
    [Abstract] [Full Text] [Related]

  • 20. Captopril test and renal duplex scanning for the primary screening of renovascular disease.
    Miralles M, Covas MI, Martínez Miralles E, Cairols M, Cotillas J, Santiso MA.
    Am J Hypertens; 1997 Nov 06; 10(11):1290-6. PubMed ID: 9397249
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.